Company Profile
UnitedHealth Group Stock Price, News & Analysis
- Ticker:
- UNH
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, UnitedHealth Group is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
409.25 USD (+0.63%)
Close
Last updated: June 23, 2026 at 00:00
371.66B USD
Market cap
Why the stock is moving
UNH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
UnitedHealth Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, UnitedHealth Group is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
UnitedHealth Group follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, UnitedHealth Group sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
Source: UnitedHealth Group
- 04
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
Source: UnitedHealth Group
- 05
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
Source: UnitedHealth Group
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of UnitedHealth Group (UNH)?
UnitedHealth Group (UNH) most recently closed at 409.25 USD, a +0.63% move versus the previous session.
What is the market cap of UnitedHealth Group (UNH)?
UnitedHealth Group currently has a market capitalization of 371.66B USD on BioPharmSignal.
What does UnitedHealth Group do?
UnitedHealth Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is UNH stock listed?
UnitedHealth Group (UNH) is associated with NYSE, Headquartered in the United States and listed on NYSE, UnitedHealth Group is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is UnitedHealth?
UnitedHealth Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is UnitedHealth Group targeting with UnitedHealth?
UnitedHealth Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Group?
UnitedHealth Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.